Insmed inc (INSM)
Income statement / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11Sep'10Jun'10
License fees

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

750

1

1

250

1

-

Other revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

11,500

-

-

-

-

-

-

-

-

-

-

-

Other expanded access program income, net

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

653

434

977

1,351

1,806

1,864

Revenues, net

36,860

45,708

38,885

29,972

21,902

9,835

0

0

0

0

0

0

0

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,403

435

978

1,601

1,807

1,864

Cost of product revenues (excluding amortization of intangible assets)

8,438

8,706

6,437

4,919

4,150

2,423

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Gross profit

28,422

-

-

-

17,752

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Operating expenses:
Research and development

36,184

32,630

34,340

33,538

31,203

39,925

39,538

35,722

30,098

33,949

26,675

26,871

22,254

54,870

23,433

23,871

20,547

19,646

19,221

18,246

17,164

14,799

15,200

14,942

11,351

9,625

12,095

12,225

10,334

11,591

5,706

7,745

4,739

7,224

6,933

8,706

5,760

769

893

Selling, general and administrative

51,346

50,206

53,347

52,433

54,810

53,960

44,445

37,160

32,653

31,404

17,408

16,644

13,715

12,181

13,716

12,262

12,520

12,944

11,024

9,706

9,542

8,267

8,204

7,874

6,728

5,970

4,747

7,544

3,975

4,247

3,647

2,238

2,525

3,050

2,472

2,745

3,256

1,636

1,884

Amortization of intangible assets

1,249

1,248

1,249

1,248

1,248

1,249

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total costs and expenses

88,779

72,728

95,373

92,138

87,261

95,134

83,983

72,882

62,751

65,353

44,083

43,515

35,969

67,051

37,149

36,133

33,067

32,590

30,245

27,952

26,706

23,066

23,404

22,816

18,079

15,595

16,842

19,769

14,309

15,838

9,353

9,983

7,264

10,274

35,395

11,451

9,016

2,405

2,777

Impairment loss

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

25,990

-

-

0

-

Operating loss

-60,357

-47,082

-56,488

-62,166

-69,509

-87,722

-83,983

-72,882

-62,751

-65,353

-44,083

-43,515

-35,969

-67,051

-37,149

-36,133

-33,067

-32,590

-30,245

-27,952

-26,706

-23,066

-23,404

-22,816

-18,079

-15,595

-16,842

-8,269

-14,309

-15,838

-9,353

-9,983

-7,264

-8,871

-34,960

-10,473

-7,415

-598

-913

Investment income

1,404

2,042

2,885

2,578

2,416

2,831

2,741

2,729

2,040

975

326

169

154

132

138

164

170

95

75

68

23

17

12

12

17

25

40

50

51

921

193

290

418

707

371

459

527

345

538

Interest expense

7,411

7,348

6,846

6,785

6,726

6,667

6,675

6,488

5,642

1,466

1,496

1,489

1,474

1,483

769

624

622

724

725

718

722

620

594

595

606

609

525

635

643

538

222

1

2

1

2

3

4

0

0

Loss on extinguishment of debt

-

-

0

0

-

-9

0

0

-2,200

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other income (expense), net

36

-276

-85

-51

-119

52

220

244

86

94

101

200

-95

27

45

32

15

3

-67

-5

36

-11

-4

175

-19

-35

0

0

2

-

-

-

-

-

-

-

-

-

-

Loss before income taxes

-66,328

-52,664

-60,534

-66,424

-73,938

-91,506

-87,697

-76,397

-68,476

-65,750

-45,152

-44,635

-37,384

-68,375

-37,735

-36,561

-33,504

-33,216

-30,962

-28,607

-27,369

-23,680

-23,990

-23,224

-18,687

-16,214

-17,327

-8,854

-14,899

-15,455

-9,382

-9,694

-6,843

-8,164

-34,591

-10,017

-6,892

-253

-375

Gain on sale of assets, net

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

5

-

0

0

0

-

-

Provision for income taxes

0

377

100

100

200

201

0

0

0

-366

27

37

30

27

25

18

28

-

-

-

-

-6,033

0

0

-4,389

0

0

0

-1,221

-4

0

2

2

-2

0

0

2

77

3

Net loss

-66,364

-52,988

-60,682

-66,514

-74,153

-91,573

-87,743

-76,437

-68,524

-65,384

-45,179

-44,672

-37,414

-68,402

-37,760

-36,579

-33,532

-31,245

-30,962

-28,607

-27,369

-17,647

-23,990

-23,224

-14,298

-

-

-

-

-

-

-

-

-8,162

-34,591

-10,017

-6,894

-330

-378

Basic and diluted net loss per share (in dollars per share)

-0.74

-0.56

-0.68

-0.81

-0.96

-1.19

-1.14

-1.00

-0.89

-0.88

-0.69

-0.72

-0.60

-1.11

-0.61

-0.59

-0.54

-0.50

-0.50

-0.47

-0.55

-0.35

-0.54

-0.59

-0.36

-0.43

-0.46

-0.28

-0.43

-0.51

-0.38

-0.39

-0.28

-0.31

-1.39

-0.40

-0.85

-0.03

-0.03

Weighted average basic and diluted common shares outstanding

89,779

89,648

89,245

81,806

77,541

77,104

77,066

76,767

76,619

76,742

65,312

62,209

62,041

61,954

61,878

61,878

61,858

61,968

61,774

60,833

49,957

49,785

44,082

39,273

39,240

39,223

37,389

31,754

31,554

31,432

25,013

24,875

24,860

49,720

24,833

24

18,814

13,030

13,025

Accretion of beneficial conversion charge

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-9,175

0

0

Net loss

-66,364

-52,988

-60,682

-66,514

-74,153

-91,573

-87,743

-76,437

-68,524

-

-

-

-37,414

-68,402

-37,760

-36,579

-33,532

-31,245

-30,962

-28,607

-27,369

-

-

-

-

-

-

-

-

-15,451

-9,382

-9,696

-6,845

-8,162

-34,591

-10,017

-16,069

-330

-378

Other comprehensive income (loss):
Foreign currency translation (losses) gains

-37

-2

-1

-37

39

-29

2

-21

42

-37

76

5

18

-60

-17

15

-3

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net loss attributable to common stockholders

-66,364

-52,988

-60,682

-66,514

-74,153

-91,573

-87,743

-76,437

-68,524

-

-

-

-37,414

-

-37,760

-36,579

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-9,382

-9,696

-6,845

-8,162

-34,591

-10,017

-16,069

-330

-378

Unrealized loss on investments, net of taxes

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-835

199

-30

216

-

-

-

-

-

-

Total comprehensive loss

-66,401

-52,990

-60,683

-66,551

-74,114

-91,602

-87,741

-76,458

-68,482

-65,421

-45,103

-44,667

-37,396

-68,462

-37,777

-36,564

-33,535

-31,245

-30,962

-28,607

-27,369

-

-

-

-

-

-17,327

-8,854

-13,678

-16,286

-9,183

-9,726

-6,629

-17,758

-34,837

-9,714

-7,073

-

-

Weighted average diluted common shares outstanding (in shares)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

13,025